Eli Lilly's Covid-19 antibody treatment shows promise, company says
8th Oct 2020 11:42
(Sharecast News) - US drug giant Eli Lilly's monoclonal antibody treatment is effective in reducing levels of the novel coronavirus in patients and appears to be able to keep them from having to go go the emergency room or hospital, the company said.
Read moreAstraZeneca gets another FDA nod for Farxiga
2nd Oct 2020 07:28
(Sharecast News) - AstraZeneca announced on Friday that 'Farxiga' or dapagliflozin, has been granted Breakthrough Therapy Designation by the US Food and Drug Administration (FDA) for patients with chronic kidney disease, with and without type-2 diabetes.
Read moreModerna Covid-19 vaccine may be ready for full-scale use by early Q2 2020
1st Oct 2020 09:04
(Sharecast News) - Moderna's Covid-19 vaccine candidate will not be ready by the 3 November presidential elections in the US, but it could be by the end of that month.
Read moreFDA expands probe into AstraZeneca Covid-19 vaccine candidate
1st Oct 2020 07:30
(Sharecast News) - America's main health regulator, the Food and Drug Administration, has widened its investigation into the adverse event related to one patient in AstraZeneca's ongoing phase three clinical trial of its Covid-19 vaccine candidate, Reuters reported, which remains on hold in the States.
Read moreLondon pre-open: Stocks set for higher start on US stimulus hopes
1st Oct 2020 07:28
(Sharecast News) - Futures are pointing to a positive start to the month and to the fourth quarter for stocks in London, buoyed by news overnight that US lawmakers were narrowing their differences over the proposed size of a fourth government stimulus package.
Read moreCovid-19 deaths reach 1m, WHO claims virus still suppressible
29th Sep 2020 11:23
(Sharecast News) - The World Health Organization (WHO) said on Tuesday that the number of global deaths from Covid-19 had reached 1m but that the virus was still suppressible.
Read moreInovio shares crash after FDA places partial hold on Covid-19 trial
28th Sep 2020 13:30
(Sharecast News) - Inovio's phase 2/3 trial of its Covid-19 vaccine candidate was put on partial hold by the US Food and Drug Administration, sending the shares crashing.
Read moreAstraZeneca 'under fire' for vaccine safety, NYT says
21st Sep 2020 12:48
(Sharecast News) - AstraZeneca disclosed details of its Covid-19 vaccine trials at the weekend to address criticism around pharmaceutical companies' transparency and avoid the risk of engendering skepticism in the public about the safety of any potential vaccines.
Read moreAstraZeneca's Tagriso trial shows 'meaningful improvement', Lynparza recommended for EU marketing
21st Sep 2020 08:36
(Sharecast News) - Pharmaceutical giant AstraZeneca issued updates on the status of several drug candidates early on Monday.
Read moreIllness in phase three trial not linked to Covid-19 vaccine, Oxford says
17th Sep 2020 12:50
(Sharecast News) - The Covid19 vaccine being trialled by AstraZeneca and the University of Oxford was likely not behind the symptoms of one participant which led to the pause in the phase three trials last week, documents provided to the volunteers show.
Read moreNIH 'very concerned' about serious side effect in AstraZeneca vaccine trial - CNN
16th Sep 2020 15:24
(Sharecast News) - The US part of the phase three trial of the Covid-19 vaccine candidate being developed by AstraZeneca and the University of Oxford remains on hold, pending authorisation for a restart from independent safety monitors and America's health regulator, the Food and Drug Administration.
Read moreNo safety issues with Covid-19 vaccine trial so far - Pfizer
15th Sep 2020 23:25
(Sharecast News) - Pfizer's phase three clinical trial for its Covid-19 vaccine candidate has encountered no safety problems even after over 12,000 volunteers had been administered a second dose.
Read moreEurope close: Stocks end mixed despite gains for travel and leisure names
14th Sep 2020 18:57
(Sharecast News) - European stocks finished the session on a mixed note, despite news at the weekend that AstraZeneca has resumed the key clinical trial for the Covid-19 vaccine candidate that it's developing with the University of Oxford.
Read moreUniversity of Oxford and AstraZeneca restart Covid-19 vaccine trial
12th Sep 2020 15:55
(Sharecast News) - The University of Oxford and AstraZeneca will resume trials of their Covid-19 vaccine candidate after receiving clearance from the UK's Medicines Health Regulatory Authority.
Read moreAstraZeneca boss says Covid-19 vaccine may still be ready by end 2020
10th Sep 2020 14:37
(Sharecast News) - AstraZeneca's boss said that the Covid-19 vaccine that it was developing together with the University of Oxford could still be ready by the end of 2020.
Read more